P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
8.87
-0.12 (-1.33%)
May 1, 2025, 4:00 PM EDT - Market closed

Company Description

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States.

The company operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

P3 Health Partners Inc.
P3 Health Partners logo
Country United States
Founded 2015
Industry Medical Care Facilities
Sector Healthcare
Employees 360
CEO Aric Coffman

Contact Details

Address:
2370 Corporate Circle, Suite 300
Henderson, Nevada 89074
United States
Phone 702 910 3950
Website p3hp.org

Stock Details

Ticker Symbol PIII
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001832511
CUSIP Number 744413105
ISIN Number US7444131053
Employer ID 85-2992794
SIC Code 8000

Key Executives

Name Position
Dr. Aric Coffman M.D. Chief Executive Officer and President
Dr. Amir Bacchus M.B.A., M.D. Co-Founder, Chief Medical Officer and Director
Leif Pedersen Chief Financial Officer
William Bettermann Executive Vice President and Chief Operating Officer
Devery Goodey Senior Vice President of Technology
Sarah Bussmann B.S.N., CRNI, M.H.A., R.N. Chief Administrative Officer
Todd M. Smith Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Kassi Belz APR Executive Vice President of Communications, Culture and Engagement
Timothy Wilson Senior Vice President of Population Health Management
Peter Lymm Market President of Western Region

Latest SEC Filings

Date Type Title
Apr 29, 2025 DEF 14A Other definitive proxy statements
Apr 18, 2025 PRE 14A Other preliminary proxy statements
Apr 17, 2025 8-K Current Report
Apr 4, 2025 8-K Current Report
Apr 3, 2025 8-K Current Report
Apr 1, 2025 S-8 Securities to be offered to employees in employee benefit plans
Mar 28, 2025 10-K Annual Report
Mar 27, 2025 8-K Current Report
Mar 3, 2025 DEF 14A Other definitive proxy statements
Feb 20, 2025 PRE 14A Other preliminary proxy statements